- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Uproleselan
Total 14 results
-
GlycoMimetics IncorporatedQuotient SciencesCompleted
-
Lena Napolitano, MDGlycoMimetics IncorporatedTerminatedCOVID-19 PneumoniaUnited States
-
Apollomics Inc.Zhejiang CrownMab Biotech Co. LtdRecruitingRelapsed/Refractory AMLChina
-
GlycoMimetics IncorporatedActive, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Spain, Australia, Netherlands, France, Ireland, Italy, United Kingdom
-
Apollomics Inc.Zhejiang CrownMab Biotech Co. LtdRecruitingRelapsed/Refractory AMLChina
-
University of VermontNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital; GlycoMimetics IncorporatedCompleted
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisHong Kong, United States, Spain, United Kingdom, Australia, Taiwan, Belgium, Canada, India, Japan, Korea, Republic of, Singapore, Puerto Rico, France, Israel, Austria, Germany, Italy, Malaysia, New Zealand, Mexico, Poland, Switzerland, Netherlan... and more
-
John Horan, MDGlycoMimetics IncorporatedRecruitingAcute Myeloid Leukemia | Pediatric CancerUnited States
-
Brian JonasNational Cancer Institute (NCI); GlycoMimetics IncorporatedRecruitingUproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid LeukemiaAcute Myeloid LeukemiaUnited States
-
GlycoMimetics IncorporatedCompletedLeukemia, Myeloid, AcuteUnited States, Ireland, Australia
-
National Cancer Institute (NCI)Suspended
-
M.D. Anderson Cancer CenterActive, not recruitingSecondary Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)Childrens Oncology Group (COG); LLS PedAL LLCRecruitingDown Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Acute Myeloid Leukemia Post Cytotoxic Therapy | Myelodysplastic...United States